Accelrys Posts Sharp Q4 Revenue Gains | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelrys today reported a 42 percent increase in its fourth-quarter GAAP revenues year over year.

The San Diego-based bioinformatics firm reported GAAP revenues of $31.3 million for the three-month period ended Dec. 31, compared to $22.1 million for the comparable three months of 2009. On a non-GAAP basis — excluding an $11.1 million deferred revenue fair value adjustment — the firm's revenues for Q3 2010 were $42.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.